JP Morgan Chase’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
JP Morgan Chase's RMD Position: Q3 2026 in Review
JP Morgan Chase reduced its ResMed (RMD) stake by 18% in Q3 2026, selling an estimated $33.6M and leaving 679,628 shares worth $151M. The position accounts for 0.01% of the portfolio, ranked #857.
JP Morgan Chase first reported a position in RMD in Q2 2013 and has held it in 54 quarters since. The position peaked at $306M in Q4 2020. 886 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- JP Morgan Chase held 679,628 shares of ResMed worth $151M as of Q3 2026.
- JP Morgan Chase sold 153,908 ResMed shares in Q3 2026, an estimated $33.6M.
- ResMed made up 0.01% of JP Morgan Chase's portfolio in Q3 2026, its #857 holding.
- JP Morgan Chase first reported a position in ResMed in Q2 2013 and has held it in 54 quarters since.
- JP Morgan Chase's ResMed position peaked at $306M in Q4 2020.
- 886 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.